Profile
CEMI DHR-PB TMO DHR IDXX A
Company Name Chembio Diagnostics, Inc. Danaher Corporation Thermo Fisher Scientific Inc. Danaher Corporation IDEXX Laboratories, Inc. Agilent Technologies, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research
Market Cap $16.71M $916.76B $210.04B $154.09B $57.77B $40.65B
Employees 0.19K 79.00K 125.00K 61.00K 11.00K 17.90K
CEO Richard L. Eberly Rainer M. Blair Marc N. Casper Rainer M. Blair Jonathan J. Mazelsky Padraig McDonnell
Ratings
CEMI DHR-PB TMO DHR IDXX A
Quant Rating Score 4 5 3 3 3 3
Quant Rating Buy Strong Buy Neutral Neutral Neutral Neutral
Trading
CEMI DHR-PB TMO DHR IDXX A
Last Close $0.455 $1261.26 $565.24 $213.83 $722.12 $146.08
High 52 $0.46 $1261.26 $606.74 $250.59 $722.94 $152.6
Low 52 $0.46 $1261.26 $390.2 $174.64 $361.04 $99.29
Price vs. 52 Week High -1.09 % 0 % -6.84 % -14.67 % -0.11 % -4.27 %
Price vs. 52 Week Low -1.09 % 0 % 44.86 % 22.44 % 100.01 % 47.12 %
Total Return
CEMI DHR-PB TMO DHR IDXX A
1 Month Return 0 % 0 % 4.03 % -0.54 % 14.41 % 3.13 %
3 Month Return 0 % 0 % 21.07 % 7.33 % 12.49 % 27.15 %
6 Month Return 0 % 0 % 33.75 % 8.32 % 51.99 % 34.8 %
9 Month Return 0 % 0 % -2.94 % 0.8 % 54.12 % -1.29 %
YTD Return 0 % 0 % 8.65 % -6.85 % 74.66 % 8.74 %
1 Year Return 0 % 0 % 0.79 % -14.49 % 73.59 % 4.04 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
CEMI DHR-PB TMO DHR IDXX A
Dividend Yield Percentage (TTM) - 0.57 % 0.3 % 0.57 % - 0.69 %
Dividend Paid and Capex Coverage Ration (TTM) -8.75 % 2.94 % 3.54 % 2.94 % 8.09 % 4.01 %
Dividend Per Share (TTM) - 1.23 % 1.68 % 1.23 % - 0.99 %
Payout Ratio (TTM) - 24.18 % 9.48 % 24.18 % - 22.95 %
Growth
CEMI DHR-PB TMO DHR IDXX A
Asset Growth -14.53 % -8.22 % 1.03 %
Gross Profit Growth 301.57 % 1.23 % 8.63 %
Revenue Growth 30.91 % -0.06 % 6.46 %
Revenue 3 Year -2.14 % -20.76 % 25.23 %
Revenue 5 Year 1.89 % 30.38 % 69.09 %
Revenue 10 Year -37.97 % 15.17 % 218.38 %
EBIT Growth -8.77 % -7.67 % 3.47 %
Net Income Growth 31.3 % -18.16 % 5.07 %
Net Income 3 Yeari Growth Per Share -18.83 % -40.75 % 23.15 %
Net Income 5 Yeari Growth Per Share -85.03 % 49.13 % 116.76 %
Net Income 10 Yeari Growth Per Share -913.2 % 44.14 % 492.42 %
Operating Income Growth 15.01 % -1.8 % 2.84 %
Operating Cash Flow Growth (CFG) 58.9 % -6.64 % 2.48 %
Operating 3 Year CFG 2.19 % -21.78 % 27.03 %
Operating 5 Year CFG -27.63 % 65.54 % 111.28 %
Operating 10 Year CFG -648.15 % 70.94 % 378.1 %
EPS Growth 31.43 % -17.24 % 5.9 %
EPS Diluted Growth 31.43 % -17.08 % 6.06 %
Book Value Per Share -48.06 % -6.67 % 8.24 %
Share Holder 3 Year Equity Growth Per Share -48.33 % 7.23 % 138.87 %
Share Holder 5 Year Equity Growth Per Share -31.12 % 60.08 % 838.67 %
Share Holder 10 Year Equity Growth Per Share -57.84 % 103.57 % 1547.69 %
Dividend Per Share Growth - -5.75 % -
Dividend 3 Year Growth Per Share - 1.18 % -
Dividend 5 Year Growth Per Share - 42.62 % -
Dividend 10 Year Growth Per Share - 224 % -
Debt Growth -3 % -12.23 % -7.53 %
Free Cash Flow Growth 56.8 % -8.39 % 3.26 %
Updated On 31 Dec 2022 31 Dec 2024 31 Dec 2024
Profitability
CEMI DHR-PB TMO DHR IDXX A
Gross Profit Margin TTM 20.19 % 61.37 % 39.81 % 61.37 % 61.72 % 52.96 %
Return on Assets TTM -37.2 % 4.38 % 6.38 % 4.38 % 30.34 % 9.98 %
Return on Equity TTM -89.47 % 6.88 % 13.11 % 6.88 % 67.78 % 19.97 %
Return on Capital Employed TTM -87.52 % 7.31 % 9.04 % 7.31 % 61.18 % 13.97 %
Net Income Per EBT TTM 100.15 % 83.9 % 92.29 % 83.9 % 80.67 % 87.52 %
EBT Per Ebit TTM 113.99 % 77.59 % 89.34 % 77.59 % 97.51 % 96.54 %
EBIT Per Revenue TTM -42.21 % 22.17 % 18.22 % 22.17 % 31.34 % 21.27 %
Cash Flow To Debt Ratio TTM -50.61 % 37.48 % 21.44 % 37.48 % 424.21 % 43.85 %
Receivables Turnover TTM 2.58 6.46 4.91 6.46 7.35 4.91
Payables Turnover TTM 11.54 5.52 8.83 5.52 13.05 6.02
Inventory Turnover TTM 5 3.51 4.58 3.51 4.07 3.15
Fixed Asset Turnover TTM 352.21 % 451.41 % 429.75 % 451.41 % 563.59 % 345.27 %
Asset Turnover TTM 77.21 % 30.37 % 42.45 % 30.37 % 123.05 % 55.52 %
Operating Cash Flow Per Share TTM -0.52 8.89 20.24 8.89 13.58 5.25
Free Cash Flow Per Share TTM -0.58 7.06 16.17 7.06 11.91 4.92
Cash Per Share TTM 74.81 % 215 % 938.1 % 215 % 259.9 % 538.6 %
Operating Cash Flow Sales Ratio TTM -26.26 % 26.03 % 17.49 % 26.03 % 26.11 % 22.02 %
Free Cash Flow Operating Cash Flow Ratio TTM 111.43 % 79.41 % 79.87 % 79.41 % 87.64 % 93.78 %
Cash Flow Coverage Ratios TTM -50.61 % 37.48 % 21.44 % 37.48 % 424.21 % 43.85 %
Price To Free Cash Flows Ratio TTM -1.18 30.57 34.37 30.71 60.59 28.99
Price To Operating Cash Flows Ratio TTM -0.87 24.08 27.48 24.19 53.16 27.33
Price Cash Flow Ratio TTM -0.87 24.08 27.48 24.19 53.16 27.33
Income Statement (TTM)
CEMI DHR-PB TMO DHR IDXX A
Revenue $0.05B $23.88B $42.88B $23.88B $3.9B $6.51B
Gross Profit $0.01B $14.21B $17.73B $14.21B $2.38B $3.54B
Gross Profit Ratio 20.19% 59.5% 41.34% 59.5% 61.04% 54.3%
EBITDA $-0.01B $7.28B $11.8B $7.28B $1.28B $1.87B
Net Income $-0.02B $3.9B $6.34B $3.9B $0.89B $1.29B
EPS Diluted -0.96 5.29 16.53 5.29 10.67 4.43
Balance Sheet (MRQ)
CEMI DHR-PB TMO DHR IDXX A
Long Term Debt $0.01B $16.47B $30.3B $16.47B $0.55B $3.49B
Total Liabilities $0.04B $27.99B $47.65B $27.99B $1.7B $5.95B
Total Equity $0.02B $49.55B $49.67B $49.55B $1.6B $5.9B
Total Investments $0B $1.82B $2.12B $1.82B $0.06B $0.18B
Total Debt $0.03B $17.15B $32.78B $17.15B $0.99B $3.57B
Total Assets $0.06B $77.54B $97.32B $77.54B $3.29B $11.85B
Cash Flow Statement (TTM)
CEMI DHR-PB TMO DHR IDXX A
Net Income $-0.02B $3.9B $6.34B $3.9B $0.89B $1.29B
Inventory $0B $0.15B $-0.03B $0.15B $-0.03B $0.03B
Dividends Paid $0B $-0.77B $-0.58B $-0.77B $0B $-0.27B
Operating Cash Flow $-0.01B $6.69B $8.67B $6.69B $0.93B $1.75B
Capital Expenditure $-0B $-1.39B $-1.4B $-1.39B $-0.13B $-0.38B
Related Stocks
Ticker Name Price
A Agilent Technologies, Inc. 146.78
ACRS Aclaris Therapeutics, Inc. 2.255
ADVB Advanced Biomed Inc. Common Stock 0.4415
AKU Akumin Inc. 0.2887
APDN Applied DNA Sciences, Inc. 5.62
AWH Aspira Women's Health Inc. 0.082
BDSX Biodesix, Inc. 8.57
BIAF bioAffinity Technologies, Inc. 2.195
BIAFW bioAffinity Technologies, Inc. 0.35
BIOC Biocept, Inc. 0.4349
BNBX Stader BNB 3.435
BNGO Bionano Genomics, Inc. 1.67
BNGOW BioNano Genomics, Inc. WT EXP 082123 0.0036
BNR Burning Rock Biotech Limited 11.79
CDNA CareDx, Inc 16.51
CHEK Check-Cap Ltd. 1.34
CNTG Centogene N.V. 0.325
CO Global Cord Blood Corporation 2.9876
CRL Charles River Laboratories International, Inc. 167.83
CSTL Castle Biosciences, Inc. 33.51
ETFs With Exposure to CEMI
Ticker ETF Name Weight Percentage Price
ITOT iShares Core S&P Total U.S. Stock Market ETF 0 147.88
Unlock